Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein. Issue 8 (16th August 2018)

• Record Type: Journal Article
• Authors: de Wispelaere, Melissanne; Lian, Wenlong; Potisopon, Supanee; Li, Pi-Chun; Jang, Jaebong; Ficarro, Scott B.; Clark, Margaret J.; Zhu, Xuling; Kaplan, Jenifer B.; Pitts, Jared D.; Wales, Thomas E.; Wang, Jinhua; Engen, John R.; Marto, Jarrod A.; Gray, Nathanael S.; Yang, Priscilla L.
• Is Part Of: Cell chemical biology. Volume 25:Issue 8(2018)
• Page Start: 1006
• Page End: 1016.e8
• Publication Date: 2018-08-16
• Subjects: antiviral -- inhibitor of viral entry -- envelope protein inhibitor -- flavivirus inhibitor; Biochemistry -- Periodicals; 572.05
• DOI: 10.1016/j.chembiol.2018.05.011
• Languages: English
• ISSNs: 2451-9456

Abstract

Summary: Viral envelope proteins are required for productive viral entry and initiation of infection. Although the humoral immune system provides ample evidence for targeting envelope proteins as an antiviral strategy, there are few pharmacological interventions that have this mode of action. In contrast to classical antiviral targets such as viral proteases and polymerases, viral envelope proteins as a class do not have a well-conserved active site that can be rationally targeted with small molecules. We previously identified compounds that inhibit dengue virus by binding to its envelope protein, E. Here, we show that these small molecules inhibit dengue virus fusion and map the binding site of these compounds to a specific pocket on E. We further demonstrate inhibition of Zika, West Nile, and Japanese encephalitis viruses by these compounds, providing pharmacological evidence for the pocket as a target for developing broad-spectrum antivirals against multiple, mosquito-borne flavivirus pathogens. Graphical Abstract: Highlights: Small molecules targeting the dengue virus E protein inhibit membrane fusion The target of these inhibitors is a pocket conserved in other flavivirus E proteins Zika and other flaviviruses are also inhibited by compounds targeting this site These compounds block infection without the risk of antibody-dependent enhancement Abstract : Countermeasures against dengue, Zika, and other flaviviruses are a large, unmet medical need. de Wispelaere et al. validate a conserved pocket of the flavivirus envelope protein as a target for small-molecule antivirals with broad-spectrum activity against flaviviruses.